GRIN2B and major depressive disorder: A recent cross-section study indicated that decreased serum PDGF-BB was one associated biomarker for MDD, and the excitotoxicity of overexpressed NMDA receptor subunit GluN2B, which is a downstream target of PDGF-BB, might be one possible reason [88, 89].